Samsung Biologics Market Cap

Samsung Biologics has a market cap or net worth of 73.09 trillion as of March 9, 2026. Its market cap has increased by 2.70% in one year.

Market Cap

73.09T

Enterprise Value

72.54T

Revenue

4.56T

Ranking

n/a

PE Ratio

65.54

Stock Price

1,579,000.00

Market Cap Chart

Since November 10, 2016, Samsung Biologics's market cap has increased from 9.53T to 73.09T, an increase of 667.16%. That is a compound annual growth rate of 24.40%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	73.09T	-6.84%
Dec 30, 2025	78.46T	16.17%
Dec 30, 2024	67.54T	24.87%
Dec 28, 2023	54.09T	-7.43%
Dec 29, 2022	58.43T	-2.20%
Dec 30, 2021	59.75T	9.32%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Celltrion	46.51T
ALTEOGEN	19.95T
SK Biopharmaceuticals	8,058.43B
LigaChem Biosciences	7,251.90B
HLB Co., Ltd.	6,749.36B
Peptron	6,132.46B
Voronoi	5,927.74B
OliX Pharmaceuticals	4,179.31B

Market Cap Rankings